Those adjustments just keep coming. As SFGATE reported, Genentech announced 436 layoffs in April 2024, and 93 more layoffs ...

Bharat Biotech joins GSK to develop a Shigella vaccine to fight shigellosis in children, with Phase 3 trials underway and ...

Bharat Biotech has partnered with GSK to advance the Shigella vaccine altSonflex1-2-3. With strong early trial results and no ...

Tempest Therapeutics, Inc. (Nasdaq: TPST), a clinical-stage biotechnology company with a pipeline of first-in-class1 targeted ...

Bharat Biotech to advance development of GSK's Shigella vaccine candidate for severe bacterial diarrhoea: Our Bureau, Bengaluru Thursday, June 12, 2025, 15:30 Hrs [IST] Bharat Bio ...

Fapon Biopharma, a clinical-stage biotech company innovating therapeutic antibodies and fusion proteins, is pleased ...

The startup, which is backed by the venture arms of Sanofi, Roche and Novartis, is using dual adeno-associated viruses to ...

Facility provides additional funding for next steps of the Company’s growth, including the expected launch of bezuclastinib ...

Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC), a leading clinical-stage company specializing in immunotherapy ...

Robbins LLP informs stockholders that a class action was filed on behalf of investors who purchased or otherwise acquired Rocket Pharmaceuticals, Inc. securities between February 7, 2025 and May 26, ...

Oncolytics Biotech (TSX:ONC), a clinical-stage oncology immunotherapy stock, is up by more than 20 per cent after onboarding ...

Hyderabad: Bharat Biotech International Limited has announced that it has partnered with GSK plc for the ongoing development and potential use of the Shigella vaccine candidate, ...